ATF4 and metabolic disease: These lncRNA–ATF4 interactions exhibit system-specific characteristics across digestive, respiratory, immune, and skeletal diseases, underscoring their relevance in conditions such as cancer, fibrosis, metabolic disorders, and immune dysfunction.